Refine by
Cell Sorting Articles & Analysis
24 news found
Core offerings include basic magnetic beads, immunomagnetic beads, cell sorting magnetic beads, nucleic acid extraction magnetic beads and kit, probe capture magnetic beads, protein purification magnetic beads, alongside customizable options for specific biomolecules or tagged proteins. ...
These semiconductor nanocrystals, ranging from 2-10 nm in size, emit precise wavelengths of light when excited, making them ideal for high-resolution displays, solar cells, and biomedical imaging. Alfa Chemistry’s cadmium-free QDs, such as indium phosphide (InP) and silicon-based variants, are particularly sought after for their eco-friendly profile and superior performance ...
CD Bioparticles scientists can also customize strategies for attaching biological ligands to polystyrene particles for use in immunological tests and assays, cell sorting, biosensing, immunoassays (e.g., agglutination assays, ELISA, particle capture and contrast reagents), and lateral flow assays. ...
These new services can be applied to the detection of circulating autoantibodies/antigens in cells and cell membranes/ immune complexes in biopsy material/circulating immune cells. ...
Titled “Bioelectrical Cell Enrichment, Sorting, and Recovery with On-Chip Sample Prep and Monitoring,” the grant will provide $952,558 in research funding to develop new features that will be embodied in the Company’s next generation CytoR2 Platform for advanced cell sorting. ...
“AskBio’s pioneering gene editing technology is a powerful complement to our modular SORT LNP genetic medicines platform, which enables the precise delivery of a wide variety of genetic cargoes to specific organs and cells, including large, complex genetic cargoes and mixed payloads,” said Shehnaaz Suliman, M.D., MBA, M.Phil., Chief Executive ...
ByBayer AG
Phase 1 studies show improvement in cognitive factors, consistent with therapeutic potential of CY6463 to improve key features in neurological diseases CY6463 favorable tolerability and safety profile was confirmed Ariana Pharma, a leading Artificial Intelligence (AI) drug development company, in collaboration with Cyclerion Therapeutics, presented today safety and pharmacodynamic results ...
Due to these advantages, NIR quantum dots have great potential in early cancer diagnosis, tumor imaging in vivo, and high-resolution electron microscopy of cancer cells. In recent years, the development of various modification methods has expanded the potential applications of NIR quantum dots in biomedical applications. ...
Ariana Pharma, the leading Al-driven precision medicine company, has announced the first comprehensive blarcamesine pathway analysis impact using extensive data from the ANAVEX®2-73-PDD-001 Parkinson’s Disease Dementia (PDD) clinical study. Initial results were presented by Ariana Pharma at the Alzheimer’s Association International Conference (AAIC 2022) in San Diego, in ...
Ariana Pharma, the leading eXplainable Artificial Intelligence (xAI) drug development company, announce the appointments of Dr. Marion Soto as Vice President, Business Development and Bertrand Lellouche as Chief Financial Officer. The financial and commercial experience of Marion and Bertrand will further drive Ariana’s accelerated growth. Marion and Bertrand will be bringing their ...
Ariana Pharma and OmiCure announce their collaboration with the renowned CLB Cancer Center to apply OmiCure and Ariana Artificial Intelligence (AI) capabilities to find more efficient treatments for cancer patients. The data were communicated at ASCO 2022 last week and showed that Artificial Intelligence RNA-based therapeutic recommendations have the potential to expand personalized cancer ...
CytoRecovery, Inc., a leader in the marker free enrichment, sorting, and recovery of live cells, presented recent study results at the American Association for Cancer Research (AACR) Annual Meeting 2022 currently being held in New Orleans. ...
Ariana Pharma, the eXplainable Artificial Intelligence clinical development Company, announced today the presentation of Phase 2 clinical biomarker data from the ANAVEX2-73-PDD-001 Parkinson’s Disease Dementia (PDD) study at the AD/PD 2022 International Conference. MDS-UPDRS Total score improved significantly for patients treated with ANAVEX®2-73 high oral once-daily dose compared to ...
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Ariana Pharma (Cambridge, MA and Paris, France) today announced an artificial intelligence-driven, precision medicine collaboration. This collaboration is expected to identify biomarkers of response to refine patient selection to guide and accelerate the clinical development of Cyclerion’s investigational therapeutics for neurological and ...
Since its founding in 1968, Sysmex has developed its business by focusing on the hematology field (blood cell count tests), which analyzes the number, type, and size of red and white blood cells as well as platelets. Sysmex has adopted a modular concept since the launch of the XN-Series Automated Hematology Analyzer (“XN-Series”) in 2011, combining ...
(NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp. ...
Cytonome will be participating in the Phacilitate Cell and Gene Therapy World Conference in Miami from January 22nd-25th, 2018. Stop by the BioProcess Hub at Booth BPi to meet out team and learn about how the GigaSort Platform can deliver high throughput cell sorting in a manufacturing ...
Sumitomo Dainippon Pharma Co., Ltd. has installed the GigaSort Platform in their newly opened Manufacturing Plant for Regenerative Medicine & Cell Therapy in Osaka, Japan. The center is the world’s first commercial iPSC plant. The GigaSort platform is a microfluidic based cell sorting technology that allows the selection of highly ...
The second part will cover applications in cell sorting, laser trapping and probing biology. Read ...
"We've created a device that can help sort pathogens from normal cells based on their surface properties." ...